Sysmex America, Inc. showcased its exciting new hematology instruments at AACC last week. The analyzers that were on display will represent 80% of the company’s future product offering. The Sysmex® XN-Series* Hematology Analyzers enable laboratories of any size to implement advanced clinical parameters, including an all-new fluorescent platelet channel for Immature Platelet Fraction (IPF) to aid in the differential diagnosis of thrombocytopenia.
The Sysmex® XN-Series boasts a scalable, series-wide compact design, and delivers a smaller footprint that optimizes workflow and transforms productivity. The instruments are built on the concept of Silent Design®, a fusion of product design and technology, developed with the users and their workplace in mind.
These and other products from Sysmex’s hematology, urinalysis, and cell image analysis and middleware portfolio were on display at Sysmex’s AACC exhibit booth. In-booth educational presentations featured topics about hematology technology, diabetes management and advanced clinical parameters, among others.
Sysmex is a global leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems and services hospitals and healthcare networks, reference laboratories and physicians offices worldwide.
The design intent for the Sysmex XN-Series* Hematology Analyzer is to enable clinical laboratories to withstand future medical technologists shortages; and the ability to keep up with workload demands and testing complexity that may accompany an aging population.
“The human-centered approach of Silent Design, upon which the Sysmex XN-Series* Hematology Analyzers are built, provides a simplified system of operation and interface based on careful study of laboratory processes, the relationship between the operator and the instrument and how people work. These instruments are truly representative of how Sysmex is resolving current day issues in the clinical laboratory environment while advancing healthcare overall,” said Ralph Taylor, Executive Vice President, Marketing, and Business Development & Medical Affairs, Sysmex America, Inc.
Sysmex Corporation, Kobe, Japan, was awarded the Good Design Gold Award in October 2011 from Japan’s Ministry of Economy, Trade and Industry for its in vitro diagnostic system employing the company’s new Silent Design® concept.
For more information on the Sysmex XN-Series* analyzers, please click on the ‘request information’ tab below.
*Pending FDA 510(K) clearance. Not available for sale in the U.S.